Burden of heart failure on patients from China: results from a cross-sectional survey

被引:23
|
作者
Jackson, James D. S. [1 ]
Cotton, Sarah E. [1 ]
Wirta, Sara Bruce [2 ]
Proenca, Catia C. [3 ]
Zhang, Milun [4 ]
Lahoz, Raquel [5 ]
Calado, Frederico J. [5 ]
机构
[1] Adelphi Real World, Real World Res, Bollington, England
[2] Novartis Sweden AB, Cardiometabol Franchise, Real World Evidence, Stockholm, Sweden
[3] Wellmera AG, Basel, Switzerland
[4] Novartis Pharma China, Hlth Econ & Outcomes Res & Access Strategy, Beijing, Peoples R China
[5] Novartis Pharma AG, Cardiometabol Franchise, Real World Evidence, Basel, Switzerland
来源
关键词
patient burden; health-related quality of life; heart failure; survey; real-world; QUALITY-OF-LIFE; OLDER-PEOPLE; DEPRESSION; HEALTH; VALIDITY;
D O I
10.2147/DDDT.S148949
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Purpose: Little evidence exists on the burden that chronic heart failure (HF) poses specifically to patients in China. The objective of this study, therefore, was to describe the burden of HF on patients in China. Materials and methods: A cross-sectional survey of cardiologists and their patients with HF was conducted. Patient record forms were completed by 150 cardiologists for 10 consecutive patients. Patients for whom a patient record form was completed were invited to complete a patient questionnaire. Results: Most of the 933 patients (mean [SD] age 65.8 [10.2] years; 55% male; 80% retired) included in the study received care in tier 2 and 3 hospitals in large cities. Patients gave a median score of 4 on a scale from 1 (no disruption) to 10 (severe disruption) to describe how much HF disrupts their everyday life. Patients in paid employment (8%) missed 10% of work time and experienced 29% impairment in their ability to work due to HF in the previous week. All aspects of patients' health-related quality of life (QoL) were negatively affected by their condition. Mean +/- SD utility calculated by the 3-level 5-dimension EuroQol questionnaire was 0.8 +/- 0.2, and patients rated their health at 70.3 (11.5) on a 100 mm visual analog scale. Patients incurred costs associated with HF treatment, travel, and professional caregiving services. Conclusion: HF is associated with poor health-related QoL and considerable disruption in patients' lives. Novel and improved therapies are needed to reduce the burden of HF on patients and the health care system.
引用
收藏
页码:1659 / 1668
页数:10
相关论文
共 50 条
  • [41] Relationship between cardiorespiratory fitness and latitude in children and adolescents: Results from a cross-sectional survey in China
    Zhang, Ting
    Yin, Xiaojian
    Yang, Xiaofang
    Bi, Cunjian
    Li, Yuqiang
    Sun, Yi
    Li, Ming
    Zhang, Feng
    Liu, Yuan
    JOURNAL OF EXERCISE SCIENCE & FITNESS, 2021, 19 (02) : 119 - 126
  • [42] Do Parents of Children with ADHD Know the Disease? Results from a Cross-Sectional Survey in Zhejiang, China
    Fan, Xiaoli
    Ma, Ye
    Cai, Jingjing
    Zhu, Guochun
    Gao, Weijia
    Zhang, Yanyi
    Lin, Nannan
    Rao, Yanxiao
    Mao, Shujiong
    Li, Rong
    Yang, Rongwang
    CHILDREN-BASEL, 2022, 9 (11):
  • [43] Diagnostic trajectories of patients with rare cancer in the Netherlands: results from a nationwide cross-sectional survey
    Padilla, Catarina S.
    de Heus, Eline
    Reuvers, Milou J. P.
    Schrieks, Marga
    Engelen, Vivian
    Grunhagen, Dirk
    Tesselaar, Margot E. T.
    van der Graaf, Winette T. A.
    Duijts, Saskia F. A.
    Husson, Olga
    SUPPORTIVE CARE IN CANCER, 2024, 32 (12)
  • [44] How the corona pandemic affects cancer patients: Results from a cross-sectional survey in Germany
    Gaisser, Andrea
    Eckford, Rachel
    Arndt, Volker
    Baumann, Michael
    Kludt, Evelyn
    Mehlis, Katja
    Ubels, Jasper
    Winkler, Eva
    Weg-Remers, Susanne
    Schlander, Michael
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 134 - 134
  • [45] THE PSYCHO-ONCOLOGICAL BURDEN OF PATIENTS WITH AGGRESSIVE MENINGIOMA - RESULTS FROM A RETROSPECTIVE CROSS-SECTIONAL STUDY
    Jungk, Christine
    Raedel, Madlen
    Mattern-Tremper, Julia
    Warta, Rolf
    Herold-Mende, Christel
    Unterberg, Andreas
    NEURO-ONCOLOGY, 2021, 23 : 187 - 187
  • [46] CROSS-SECTIONAL SURVEY TO ASSESS THE BURDEN OF NOCTURNAL SYMPTOMS IN PATIENTS WITH COPD
    Soler, Xavier
    Siddall, James
    Small, Mark
    Bogart, Michael
    CHEST, 2020, 158 (04) : 1775A - 1775A
  • [47] Patient burden and treatment patterns in cervical radiculopathy (CR): Results from a cross-sectional survey of neuropathic pain (NeP)
    Ryan, K.
    Marchettini, P.
    Dukes, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 261 - 261
  • [48] Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.
    David H. Henry
    Hema N. Viswanathan
    Eric P. Elkin
    Shana Traina
    Shawn Wade
    David Cella
    Supportive Care in Cancer, 2008, 16 : 791 - 801
  • [49] The disease burden of myelin oligodendrocyte glycoprotein antibody disease (MOGAD): Results from a cross-sectional patient and physician survey
    Paul, Friedemann
    Zappacosta, Sofia
    Narduzzi, Silvia
    Khellaf, Meheni
    Unsworth, Mia
    Trenholm, Emily
    Levy, Michael
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 709 - 710
  • [50] Patient burden and treatment patterns in post-traumatic neuropathy: Results from a cross-sectional survey of neuropathic pain
    Ryan, K.
    van Seventer, R.
    Sadosky, A.
    Dukes, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 71 - 71